Free Case Review

Qualify In Minutes

Submit Your Info Below

Were You Diagnosed With Non-Hodgkin Lymphoma After Using Roundup®?

*WE ARE CURRENTLY ACCEPTING ROUNDUP CLAIMS INVOLVING NON-HODGKIN LYMPHOMA AND RELATED NHL SUBTYPES*

Roundup® Non-Hodgkin Lymphoma Investigation

Do You Qualify?

Bernstein Liebhard LLP is investigating legal claims on behalf of individuals who were exposed to Roundup® or other glyphosate-based weed killers and were later diagnosed with non-Hodgkin lymphoma or a related NHL subtype.


MONSANTO HAS AGREED TO PAY UP TO $7.25 BILLION UNDER A PROPOSED SETTLEMENT INVOLVING ROUNDUP AND OTHER WEED KILLER CLAIMS. The proposed settlement includes compensation for certain people diagnosed with non-Hodgkin lymphoma now or in the future.


If you or a loved one used, sprayed, mixed, handled, or otherwise came into contact with Roundup® and were later diagnosed with non-Hodgkin lymphoma, you may be eligible to speak with our legal team about a potential claim.


You may qualify if all or most of the following apply:

  • You were exposed to Roundup® or another glyphosate-based weed killer
  • Your total exposure was at least 16 hours over your lifetime, even if it occurred over multiple years
  • You were diagnosed with non-Hodgkin lymphoma or a related NHL subtype
  • Your diagnosis occurred at least one year after your first exposure to Roundup® or glyphosate
  • Your exposure occurred at home, at work, through farming, landscaping, groundskeeping, or another type of weed killer use

To see if you qualify for compensation, please contact our office today at (888) 630-5866

By submitting this form, you agree to our Terms of Service and Privacy Policy. If you checked the box above, you also consent to receive informational and conversational text messages from Bernstein Liebhard LLP regarding your legal inquiry. Message and data rates may apply. Reply STOP to opt out at any time.

TIME IS LIMITED TO FILE!

No Obligation Case Review

No Fee Guarantee

Experience That Matters

Contact us today for a free, no-hassle, phone consultation. Learn about your options and let us answer your questions before you decide on a lawyer to represent you.

We have recovered over 3.5 billion dollars for our clients. However, if we don’t win you don’t pay any costs. 

Established in 1993, our firm has the knowledge/experience necessary to bring cases against big pharma and win. We take pride in driving quality results for each client.

What This Investigation Is About

Roundup® and other glyphosate-based weed killers have been widely used in homes, farms, landscaping, groundskeeping, golf courses, nurseries, and other settings for decades.


Bernstein Liebhard LLP is currently reviewing potential legal claims involving individuals who were exposed to Roundup® or other glyphosate-based herbicides and were later diagnosed with non-Hodgkin lymphoma or a related NHL subtype.


We are currently reviewing claims involving:


• Roundup® or glyphosate weed killer exposure totaling at least 16 hours over a lifetime

• A diagnosis of non-Hodgkin lymphoma or a related NHL subtype

• A diagnosis occurring at least one year after the individual's first exposure


This investigation focuses on qualifying Roundup® exposure and specific lymphoma diagnoses. Not everyone exposed to Roundup® will qualify.


Diagnoses Under Review

We are investigating claims involving non-Hodgkin lymphoma and related NHL subtypes, including:


• Diffuse large B-cell lymphoma (DLBCL)

• Follicular lymphoma

• Chronic lymphocytic leukemia (CLL)

• Small lymphocytic lymphoma (SLL)

• Mantle cell lymphoma

• Marginal zone lymphoma

• Burkitt lymphoma

• T-cell lymphomas

• Other non-Hodgkin lymphoma subtypes


⚠️ Important: You may still qualify even if your exact lymphoma diagnosis is not listed above. Our legal team can review your specific diagnosis and exposure history.

Roundup® Exposure & Documentation

Potential claims may involve Roundup® exposure at home or through work, including farming, landscaping, groundskeeping, road or park maintenance, golf course work, nursery work, and other occupations.


To evaluate a potential claim, it is helpful to identify:


• When and where Roundup® or glyphosate exposure occurred

• How often and for how long the weed killer was used or handled

• Medical records confirming a non-Hodgkin lymphoma diagnosis

• Receipts, purchase records, photographs, work records, or other information that may help document exposure


You do not need to have every record or receipt available before contacting us. Our legal team can review the information you have and discuss the next steps.

Free Case Evaluation

Roundup® Claims was created by Bernstein Liebhard LLP to provide information about legal claims involving Roundup® and other glyphosate-based weed killers and their alleged connection to non-Hodgkin lymphoma. If you or a loved one was exposed to Roundup® or another glyphosate weed killer and was later diagnosed with non-Hodgkin lymphoma or a related NHL subtype, Bernstein Liebhard LLP may be able to help you pursue compensation for your injuries and losses.


Contact us for a free, confidential case evaluation. There is no obligation to proceed.

Why Choose Bernstein Liebhard LLP?

  • Nationally Recognized: Over 30 years of experience in complex litigation.
  • Proven Success: Recovered over $3.5 billion for our clients.
  • No Fees Unless You Win: We only get paid if we recover money for you.
  • Personal Attention: Dedicated legal team guiding you every step of the way.

Our attorneys are trusted leaders in mass tort litigation, fighting for justice against some of the world’s largest pharmaceutical companies.

Free Case Review

Qualify In Minutes

Submit Your Info Above

logo

Your Advocates. Your Attorneys.

Sandy A. Liebhard

Partner

Sandy A. Liebhard is a 1988 graduate of Brooklyn Law School and since that time he has been successfully representing plaintiffs in complex litigations. Mr. Liebhard served on the Plaintiffs’ Executive Committee in In re Initial Public Offering Securities Litigation ($586 million recovery) and was involved in the In re Fannie Mae Securities Litigation, where a $153 million settlement received final approval.

Daniel C. Burke

Partner

Daniel C. Burke earned his bachelor’s degree in 1990 from the State University of New York at Albany (B.A., English/History), and earned his J.D. in 1993 from St. John’s University School of Law, where he was a member of St. John’s Journal of Legal Commentary.

Ryan S. Sharp

Associate

Ryan S. Sharp received his bachelor’s degree in 2009 from SUNY Albany (Bachelor of Political Science). He received his J.D. in 2016 from Pace University School of Law. He was chosen to be part of the second inaugural class of the New York State Pro Bono Scholar Program in his last year at Pace University School of Law. Mr. Sharp has also been recognized as a “Rising Star” by Super Lawyers from 2018 to 2023.

Free Case Evaluation

medicalscopeclaim.com was created by the attorneys at Bernstein Liebhard LLP to provide information about litigation involving contaminated endoscopic equipment used in hospitals and surgical centers nationwide. If you developed a serious infection after an endoscopic procedure—potentially from inadequately sterilized reusable medical scopes such as Olympus duodenoscopes—Bernstein Liebhard LLP may be able to help you recover compensation for your medical expenses, infections, and losses.

Qualify In Minutes.You May Be Entitled To Compensation